IDO predicts death in NEN

Prof. Joerg Schefold of the Bern University Hospital, Switzerland talks about his latest publication in Neuroendocrinology – ‘Increased activity of the immunoregulatory enzyme Indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia’.
Interview by Dr Julie Ann Lough